InvestorNewsBreaks – Amesite Inc. (NASDAQ: AMST) Partner with Five Healthcare Companies to Launch Proprietary NurseMagic(TM) Pilot Programs

Posted

Amesite (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of business-to-consumer (“B2C”) and business-to-business (“B2B”) artificial-intelligence (“AI”)-driven solutions, has launched pilot programs in five home health agencies and skilled nursing facilities across the United States. According to the company, these companies and their franchises employ more than 30,000 individuals, who serve in a wide array of nursing roles.

“We anticipate very significant quarter-to-quarter revenue increases with NurseMagic,” said Amesite founder and CEO Dr. Ann Marie Sastry in the press release. “For less than 2% of the cost of wages, our technology can make this entire workforce at least 30% more productive, while simultaneously improving the quality of patient care. Considering the total wages in this sector are approximately $130 Billion annually, we view the revenue potential for Amesite to be significant. We also believe that our customers’ risk will be reduced because of the quality and accuracy of the app in delivering requisite documentation and other guidance. Because of the efficiency of our systems, we believe that we can do so at highly attractive margins that enable sustained growth. The need for NurseMagic is acute with high turnover, staffing shortages and unmet needs in home health care. We are addressing market pain directly with our proprietary technology.”

To view the full press release, visit https://ibn.fm/6JngP

About Amesite Inc.

Amesite is a pioneering technology company specializing in the development and marketing of business-to-consumer (“B2C) and business-to-business (“B2B”) artificial intelligence (“AI”)-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic(TM), the company’s mobile healthcare app, streamlines creation of nursing notes and documentation tasks, enhances patient communication and offers personalized guidance to nurses on patient care, medications and handling challenging workplace situations. The Preacto(TM) (beta) is a personal safety application designed to provide real-time alerts and guidance in the event of emergency situations, including active shooter response. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWireLos Angeles, CAwww.InvestorWire.com310.299.1717 OfficeEditor@InvestorWire.com

InvestorWire is powered by IBN